English
简体中文
Total: £ 56.28
Published Date: 2024-07-18 | Pages: 88 | Tables: 163 | Medical Care
The global Blood Cancer Molecular Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Blood Cancer Molecular Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Blood Cancer Molecular Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Blood Cancer Molecular Diagnostics in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Blood Cancer Molecular Diagnostics include Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Agilent, Liferiver, Gpmedical and Zeesan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Blood Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Cancer Molecular Diagnostics.
Report Scope
The Blood Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Agilent
Liferiver
Gpmedical
Zeesan
Berry Oncology
Annoroad
Segment by Type
Polymerase Chain Reaction
Molecular Hybridization
Biochip
Others
Segment by Application
Hospital
Third-Party Testing Agency
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Cancer Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Polymerase Chain Reaction
1.2.3 Molecular Hybridization
1.2.4 Biochip
1.2.5 Others
1.3 Market by Application
1.3.1 Global Blood Cancer Molecular Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Third-Party Testing Agency
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Cancer Molecular Diagnostics Market Perspective (2019-2030)
2.2 Blood Cancer Molecular Diagnostics Growth Trends by Region
2.2.1 Global Blood Cancer Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blood Cancer Molecular Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Blood Cancer Molecular Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Blood Cancer Molecular Diagnostics Market Dynamics
2.3.1 Blood Cancer Molecular Diagnostics Industry Trends
2.3.2 Blood Cancer Molecular Diagnostics Market Drivers
2.3.3 Blood Cancer Molecular Diagnostics Market Challenges
2.3.4 Blood Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Blood Cancer Molecular Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Blood Cancer Molecular Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Blood Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Cancer Molecular Diagnostics Revenue
3.4 Global Blood Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Blood Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Cancer Molecular Diagnostics Revenue in 2023
3.5 Blood Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Blood Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Blood Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Blood Cancer Molecular Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Blood Cancer Molecular Diagnostics Forecasted Market Size by Type (2025-2030)
5 Blood Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Blood Cancer Molecular Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Blood Cancer Molecular Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Blood Cancer Molecular Diagnostics Market Size (2019-2030)
6.2 North America Blood Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Blood Cancer Molecular Diagnostics Market Size by Country (2019-2024)
6.4 North America Blood Cancer Molecular Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Cancer Molecular Diagnostics Market Size (2019-2030)
7.2 Europe Blood Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Blood Cancer Molecular Diagnostics Market Size by Country (2019-2024)
7.4 Europe Blood Cancer Molecular Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Cancer Molecular Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Blood Cancer Molecular Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Blood Cancer Molecular Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Blood Cancer Molecular Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Cancer Molecular Diagnostics Market Size (2019-2030)
9.2 Latin America Blood Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Blood Cancer Molecular Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Blood Cancer Molecular Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Cancer Molecular Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Blood Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Blood Cancer Molecular Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Blood Cancer Molecular Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Detail
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Blood Cancer Molecular Diagnostics Introduction
11.1.4 Roche Diagnostics Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Blood Cancer Molecular Diagnostics Introduction
11.2.4 Abbott Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Detail
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Blood Cancer Molecular Diagnostics Introduction
11.3.4 Thermo Fisher Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024)
11.3.5 Thermo Fisher Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Detail
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Blood Cancer Molecular Diagnostics Introduction
11.4.4 Qiagen Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024)
11.4.5 Qiagen Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina Blood Cancer Molecular Diagnostics Introduction
11.5.4 Illumina Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024)
11.5.5 Illumina Recent Development
11.6 Agilent
11.6.1 Agilent Company Detail
11.6.2 Agilent Business Overview
11.6.3 Agilent Blood Cancer Molecular Diagnostics Introduction
11.6.4 Agilent Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024)
11.6.5 Agilent Recent Development
11.7 Liferiver
11.7.1 Liferiver Company Detail
11.7.2 Liferiver Business Overview
11.7.3 Liferiver Blood Cancer Molecular Diagnostics Introduction
11.7.4 Liferiver Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024)
11.7.5 Liferiver Recent Development
11.8 Gpmedical
11.8.1 Gpmedical Company Detail
11.8.2 Gpmedical Business Overview
11.8.3 Gpmedical Blood Cancer Molecular Diagnostics Introduction
11.8.4 Gpmedical Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024)
11.8.5 Gpmedical Recent Development
11.9 Zeesan
11.9.1 Zeesan Company Detail
11.9.2 Zeesan Business Overview
11.9.3 Zeesan Blood Cancer Molecular Diagnostics Introduction
11.9.4 Zeesan Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024)
11.9.5 Zeesan Recent Development
11.10 Berry Oncology
11.10.1 Berry Oncology Company Detail
11.10.2 Berry Oncology Business Overview
11.10.3 Berry Oncology Blood Cancer Molecular Diagnostics Introduction
11.10.4 Berry Oncology Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024)
11.10.5 Berry Oncology Recent Development
11.11 Annoroad
11.11.1 Annoroad Company Detail
11.11.2 Annoroad Business Overview
11.11.3 Annoroad Blood Cancer Molecular Diagnostics Introduction
11.11.4 Annoroad Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024)
11.11.5 Annoroad Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Blood Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Polymerase Chain Reaction
Table 3. Key Players of Molecular Hybridization
Table 4. Key Players of Biochip
Table 5. Key Players of Others
Table 6. Global Blood Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Blood Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Blood Cancer Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Blood Cancer Molecular Diagnostics Market Share by Region (2019-2024)
Table 10. Global Blood Cancer Molecular Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Blood Cancer Molecular Diagnostics Market Share by Region (2025-2030)
Table 12. Blood Cancer Molecular Diagnostics Market Trends
Table 13. Blood Cancer Molecular Diagnostics Market Drivers
Table 14. Blood Cancer Molecular Diagnostics Market Challenges
Table 15. Blood Cancer Molecular Diagnostics Market Restraints
Table 16. Global Blood Cancer Molecular Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Blood Cancer Molecular Diagnostics Market Share by Players (2019-2024)
Table 18. Global Top Blood Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Cancer Molecular Diagnostics as of 2023)
Table 19. Ranking of Global Top Blood Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Blood Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Blood Cancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Blood Cancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Blood Cancer Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Blood Cancer Molecular Diagnostics Revenue Market Share by Type (2019-2024)
Table 27. Global Blood Cancer Molecular Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Blood Cancer Molecular Diagnostics Revenue Market Share by Type (2025-2030)
Table 29. Global Blood Cancer Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Blood Cancer Molecular Diagnostics Revenue Market Share by Application (2019-2024)
Table 31. Global Blood Cancer Molecular Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Blood Cancer Molecular Diagnostics Revenue Market Share by Application (2025-2030)
Table 33. North America Blood Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Blood Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Blood Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Blood Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Blood Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Blood Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Blood Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Blood Cancer Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Blood Cancer Molecular Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Blood Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Blood Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Blood Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Blood Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Blood Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Blood Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 48. Roche Diagnostics Company Detail
Table 49. Roche Diagnostics Business Overview
Table 50. Roche Diagnostics Blood Cancer Molecular Diagnostics Product
Table 51. Roche Diagnostics Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 52. Roche Diagnostics Recent Development
Table 53. Abbott Company Detail
Table 54. Abbott Business Overview
Table 55. Abbott Blood Cancer Molecular Diagnostics Product
Table 56. Abbott Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 57. Abbott Recent Development
Table 58. Thermo Fisher Company Detail
Table 59. Thermo Fisher Business Overview
Table 60. Thermo Fisher Blood Cancer Molecular Diagnostics Product
Table 61. Thermo Fisher Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 62. Thermo Fisher Recent Development
Table 63. Qiagen Company Detail
Table 64. Qiagen Business Overview
Table 65. Qiagen Blood Cancer Molecular Diagnostics Product
Table 66. Qiagen Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 67. Qiagen Recent Development
Table 68. Illumina Company Detail
Table 69. Illumina Business Overview
Table 70. Illumina Blood Cancer Molecular Diagnostics Product
Table 71. Illumina Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 72. Illumina Recent Development
Table 73. Agilent Company Detail
Table 74. Agilent Business Overview
Table 75. Agilent Blood Cancer Molecular Diagnostics Product
Table 76. Agilent Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 77. Agilent Recent Development
Table 78. Liferiver Company Detail
Table 79. Liferiver Business Overview
Table 80. Liferiver Blood Cancer Molecular Diagnostics Product
Table 81. Liferiver Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 82. Liferiver Recent Development
Table 83. Gpmedical Company Detail
Table 84. Gpmedical Business Overview
Table 85. Gpmedical Blood Cancer Molecular Diagnostics Product
Table 86. Gpmedical Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 87. Gpmedical Recent Development
Table 88. Zeesan Company Detail
Table 89. Zeesan Business Overview
Table 90. Zeesan Blood Cancer Molecular Diagnostics Product
Table 91. Zeesan Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 92. Zeesan Recent Development
Table 93. Berry Oncology Company Detail
Table 94. Berry Oncology Business Overview
Table 95. Berry Oncology Blood Cancer Molecular Diagnostics Product
Table 96. Berry Oncology Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 97. Berry Oncology Recent Development
Table 98. Annoroad Company Detail
Table 99. Annoroad Business Overview
Table 100. Annoroad Blood Cancer Molecular Diagnostics Product
Table 101. Annoroad Revenue in Blood Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 102. Annoroad Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Cancer Molecular Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Blood Cancer Molecular Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Polymerase Chain Reaction Features
Figure 4. Molecular Hybridization Features
Figure 5. Biochip Features
Figure 6. Others Features
Figure 7. Global Blood Cancer Molecular Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Blood Cancer Molecular Diagnostics Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Third-Party Testing Agency Case Studies
Figure 11. Others Case Studies
Figure 12. Blood Cancer Molecular Diagnostics Report Years Considered
Figure 13. Global Blood Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Blood Cancer Molecular Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Blood Cancer Molecular Diagnostics Market Share by Region: 2023 VS 2030
Figure 16. Global Blood Cancer Molecular Diagnostics Market Share by Players in 2023
Figure 17. Global Top Blood Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Cancer Molecular Diagnostics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Blood Cancer Molecular Diagnostics Revenue in 2023
Figure 19. North America Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Blood Cancer Molecular Diagnostics Market Share by Country (2019-2030)
Figure 21. United States Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Blood Cancer Molecular Diagnostics Market Share by Country (2019-2030)
Figure 25. Germany Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Blood Cancer Molecular Diagnostics Market Share by Region (2019-2030)
Figure 33. China Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Blood Cancer Molecular Diagnostics Market Share by Country (2019-2030)
Figure 41. Mexico Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Blood Cancer Molecular Diagnostics Market Share by Country (2019-2030)
Figure 45. Turkey Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Blood Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Roche Diagnostics Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2019-2024)
Figure 48. Abbott Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2019-2024)
Figure 49. Thermo Fisher Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2019-2024)
Figure 50. Qiagen Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2019-2024)
Figure 51. Illumina Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2019-2024)
Figure 52. Agilent Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2019-2024)
Figure 53. Liferiver Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2019-2024)
Figure 54. Gpmedical Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2019-2024)
Figure 55. Zeesan Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2019-2024)
Figure 56. Berry Oncology Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2019-2024)
Figure 57. Annoroad Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
